Author Archives: Jason Carr

Morgan Stanley Sticks to Their Sell Rating for Lennox International (LII)

Morgan Stanley analyst Joshua Pokrzywinski maintained a Sell rating on Lennox International (LII – Research Report) today and set a price target of $211.00. The company’s shares closed last Monday at $248.17. According to TipRanks.com, Pokrzywinski is a 3-star analyst

Analysts’ Opinions Are Mixed on These Technology Stocks: Zscaler Inc (NASDAQ: ZS) and NIC Inc (NASDAQ: EGOV)

Analysts have been eager to weigh in on the Technology sector with new ratings on Zscaler Inc (ZS – Research Report) and NIC Inc (EGOV – Research Report). Zscaler Inc (ZS) In a report released today, Melissa Franchi from Morgan

Mizuho Securities Sticks to Their Hold Rating for Biogen Inc (BIIB)

Mizuho Securities analyst Salim Syed maintained a Hold rating on Biogen Inc (BIIB – Research Report) today and set a price target of $235.00. The company’s shares closed last Monday at $223.51, close to its 52-week low of $215.78. According

Analysts’ Top Consumer Goods Picks: Koppers Holdings Inc (KOP), Superior Uniform Group (SGC)

There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Koppers Holdings Inc (KOP – Research Report) and Superior Uniform Group (SGC – Research Report) with bullish sentiments. Koppers Holdings Inc

Seattle Genetics (SGEN) Receives a Buy from H.C. Wainwright

In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on Seattle Genetics (SGEN – Research Report), with a price target of $140.00. The company’s shares closed last Monday at $100.89, close to its 52-week high

Analysts Are Bullish on These Healthcare Stocks: Blueberries Medical Corp (BBRRF), Spectrum Pharmaceuticals (SPPI)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Blueberries Medical Corp (BBRRF – Research Report), Spectrum Pharmaceuticals (SPPI – Research Report) and Vertex Pharmaceuticals (VRTX – Research Report) with bullish